Chief and program director of stem cell transplantation and physician at Dana-Farber Cancer Institute, as well as professor of medicine at Harvard Medical School in Boston, Massachusetts
This issue features a look at the hidden costs of importing lower-cost drugs, the optimal hemophilia treatment, the limits of genetic testing, and more.
